Small study probes emotion reading in bipolar disorder
NCT ID NCT05922956
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well people with bipolar I and bipolar II disorder recognize facial emotions compared to healthy individuals. Ten participants completed a facial emotion recognition test and questionnaires. The goal was to see if there are differences between the two bipolar types and healthy controls, and how emotion recognition relates to self-esteem and well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help design better social-cognition therapies for people with bipolar disorder.
- What could go wrong
- This is a very small, completed observational study (10 participants) that only measures differences, not treatments. Results may not apply to larger or more diverse groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
10 people
The number who actually took part.
- Started
-
Apr 2020
- Finished
-
Jul 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient group : * Male or female patients, between 18 and 60 years old * Diagnosis of Bipolar Disorder I or Bipolar Disorder II according to DSM-IV criteria, using the French version of the Mini-International Neuropsychiatric Interview (MINI) * Strictly euthymic defined by Hamilton Depression Rating Scale (17 items) ≤ 5 and Young Mania Rating Scale ≤ 5 for at least two months. * Native French speakers * Affiliated to the French social security system * Giving their written informed consent Control group : * Male or female control subjects, aged between 18 and 60 years old, assessed using TREF * Native French speakers * Giving their written informed consent Exclusion Criteria: * Patient group : * History of mental retardation assessed by the French version of the National Adult Reading Test * Neurological illness or any clinical condition that could affect cognitive performance (history of head injury with loss of consciousness lasting more than 5 minutes multiple sclerosis, stroke etc.) * Electroconvulsive therapy within the last 6 months * Alcohol and Drug dependence (except tobacco and caffeine) according to DSM-IV criteria using the French version of the Mini-International Neuropsychiatric Interview (MINI). * Learning disability or difficulty with fluent use of the French language * Patient with mandatory care * Long-Term use of non-psychotropic medication with psychotropic effects (opiates, Baclofen) Control group : * History of mental retardation estimated by the French version of the National Adult Reading Test * Neurological illness or any clinical condition that could affect cognitive performance (history of head injury with loss of consciousness lasting more than 5 minutes multiple sclerosis, stroke etc.) * Current Mood disorder/ Lifetime Psychotic Disorder according to DSM-IV criteria using the French version of the Mini-International Neuropsychiatric Interview (MINI) * Neither history of psychotic or affective disorders in a first-degree family member * Alcohol and Drug dependence (except tobacco and caffeine) according to DSM-IV criteria using the French version of the Mini-International Neuropsychiatric Interview (MINI) * Learning disability or difficulty with fluent use of the French language * Long-Term use of non-psychotropic drugs with psychotropic effects (opiates, Baclofen) and psychotropic drugs
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bipolar disorder I and II are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens
Amiens, 80480, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a nasal insulin spray rev up brain energy and sharpen thinking in psychosis?
- Could immune cells hold clues to bipolar disorder?
- Can brain tests unlock the social struggles of turner syndrome?
- Brain scans reveal the hidden mechanics of trust and cooperation
- Can brain implants read and treat bipolar depression without triggering mania?